[HTML] frontiersin.org

[HTML][HTML] Circulating biomarkers in prostate cancer

M Nagata, S Horie, Y Ma - Frontiers in Oncology, 2024 - frontiersin.org
Prostate cancer is the fifth leading cause of cancer death worldwide and biomarkers with
improved specificity and sensitivity are in urgent need for precise prognosis and diagnose …
被引用次数：1 相关文章
[HTML] nih.gov

[HTML][HTML] Circulating biomarkers in prostate cancer

M Nagata, S Horie, Y Ma - Frontiers in Oncology, 2024 - ncbi.nlm.nih.gov
Prostate cancer is the fifth leading cause of cancer death worldwide and biomarkers with
improved specificity and sensitivity are in urgent need for precise prognosis and diagnose …

Circulating biomarkers in prostate cancer.

M Nagata, S Horie, Y Ma - Frontiers in Oncology, 2024 - europepmc.org
Prostate cancer is the fifth leading cause of cancer death worldwide and biomarkers with
improved specificity and sensitivity are in urgent need for precise prognosis and diagnose …

[引用][C] Circulating biomarkers in prostate cancer

M Nagata, S Horie, Y Ma - Frontiers in oncology, 2024 - pubmed.ncbi.nlm.nih.gov
Editorial: Circulating biomarkers in prostate cancer Editorial: Circulating biomarkers in
prostate cancer Front Oncol. 2024 Feb 7:14:1365353. doi: 10.3389/fonc.2024.1365353 …

[引用][C] Circulating biomarkers in prostate cancer.

M Nagata, S Horie, Y Ma - Frontiers in Oncology, 2024 - europepmc.org
Editorial: Circulating biomarkers in prostate cancer. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …